Telomir Pharmaceuticals, Inc. (TELO)
NASDAQ: TELO · Real-Time Price · USD
0.4205
-0.0026 (-0.61%)
At close: Nov 18, 2026, 4:00 PM EST
0.4500
+0.0295 (7.02%)
After-hours: Nov 18, 2026, 7:30 PM EST
Telomir Pharmaceuticals Market Cap
Telomir Pharmaceuticals has a market cap or net worth of $30.98 million as of November 18, 2026. It is the 33,267th most valuable company in the world and the 4,844th biggest in the United States. Its market cap has decreased by 35.64% in one year.
Market Cap
30.98M
Enterprise Value
26.53M
1-Year Change
-35.64%
Global Rank
Country Rank
#4,844 United States
Category
ChartMarket Cap Chart
Since the IPO on February 9, 2024, Telomir Pharmaceuticals's market cap has decreased from $207.27M to $30.98M, a decrease of -85.05%. That is a compound annual growth rate of -49.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 30.98M | -32.25% |
| Dec 31, 2025 | 45.73M | -62.70% |
| Dec 31, 2024 | 122.58M | -40.86% |
| Feb 9, 2024 | 207.27M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kalaris Therapeutics | 33.09M |
| OS Therapies | 32.35M |
| NextCure | 31.72M |
| Alterity Therapeutics | 31.22M |
| Rein Therapeutics | 30.68M |
| BriaCell Therapeutics | 30.27M |
| NanoViricides | 30.12M |
| Adicet Bio | 29.79M |